2007 - AAI Lifetime Achievement Award, American Association of Immunologists
2007 - American Association of Immunologists Lifetime Achievement Award
2006 - Member of the National Academy of Medicine (NAM)
2003 - Fellow of the American Academy of Arts and Sciences
2002 - AAI Excellence in Mentoring Award, American Association of Immunologists
1994 - Member of the National Academy of Sciences
1991 - Excellence in Science Award, Federation of American Societies for Experimental Biology (FASEB)
Her scientific interests lie mostly in Immunology, Molecular biology, Antibody, Antigen and Immunotoxin. Her Immunology research incorporates themes from Internal medicine, Transplantation and Stem cell. Her Molecular biology study combines topics in areas such as T cell, Lymphokine, Immunoglobulin M, Surface Immunoglobulin and Cytotoxic T cell.
As a part of the same scientific family, Ellen S. Vitetta mostly works in the field of Antibody, focusing on Spleen and, on occasion, Cell. Her Antigen study deals with B cell intersecting with B-1 cell. Her work carried out in the field of Immunotoxin brings together such families of science as Lymphoma, Pathology, Cancer research and Ricin.
Ellen S. Vitetta mainly investigates Molecular biology, Immunology, Antibody, Antigen and Immunotoxin. She combines subjects such as B-1 cell, T cell, B cell, Immunoglobulin D and Cytotoxic T cell with her study of Molecular biology. Her studies examine the connections between Immunology and genetics, as well as such issues in Transplantation, with regards to Stem cell.
Her work deals with themes such as Cell culture and Virology, which intersect with Antibody. Ellen S. Vitetta combines subjects such as Immunoprecipitation, Spleen, Receptor and CD40 with her study of Antigen. Her Immunotoxin research focuses on Ricin and how it relates to Recombinant DNA.
Her primary scientific interests are in Immunology, Monoclonal antibody, Antibody, Ricin and Immunotoxin. The various areas that Ellen S. Vitetta examines in her Immunology study include Stem cell, Transplantation and Graft-versus-host disease. The concepts of her Monoclonal antibody study are interwoven with issues in Molecular biology, Cancer research, Cell culture and In vivo.
As part of her studies on Molecular biology, she often connects relevant areas like B cell. Her work carried out in the field of Antibody brings together such families of science as In vitro and Lethal dose. Her Immunotoxin study also includes fields such as
Ellen S. Vitetta mainly focuses on Immunology, Antibody, Monoclonal antibody, Internal medicine and Immunotoxin. Her Immunology research includes themes of In vivo and Graft-versus-host disease, Transplantation. Her studies in Antibody integrate themes in fields like Clinical trial, Recombinant DNA, Ricin and Virology.
Her research in Monoclonal antibody intersects with topics in Epitope, Cell culture, In vitro and Immunoglobulin G. Her In vitro study incorporates themes from Molecular biology, Biophysics and Monoclonal. Her Immunotoxin study combines topics in areas such as Cancer research and Refractory.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells
Tracy L. Stevens;Alexis Bossie;Virginia M. Sanders;Rafael Fernandez-Botran.
Nature (1988)
HER-2 gene amplification can be acquired as breast cancer progresses.
Songdong Meng;Debasish Tripathy;Sanjay Shete;Raheela Ashfaq.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor.
Randolph Noelle;Peter H. Krammer;Junichi Ohara;Jonathan W. Uhr.
Proceedings of the National Academy of Sciences of the United States of America (1984)
Redesigning nature's poisons to create anti-tumor reagents.
ES Vitetta;RJ Fulton;RD May;M Till.
Science (1987)
T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells.
Peter C. Isakson;Peter C. Isakson;Ellen Pure;Ellen Pure;Ellen S. Vitetta;Ellen S. Vitetta;Peter H. Krammer.
Journal of Experimental Medicine (1982)
SEROLOGICAL, BIOCHEMICAL, AND FUNCTIONAL IDENTITY OF B CELL-STIMULATORY FACTOR 1 AND B CELL DIFFERENTIATION FACTOR FOR IgG1
Ellen S. Vitetta;Junichi Ohara;Christopher D. Myers;Judith E. Layton.
Journal of Experimental Medicine (1985)
Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells.
R. Fernandez-Botran;V. M. Sanders;T. R. Mosmann;Ellen S Vitetta.
Journal of Experimental Medicine (1988)
CELL SURFACE IMMUNOGLOBULIN II. ISOLATION AND CHARACTERIZATION OF IMMUNOGLOBULIN FROM MOUSE SPLENIC LYMPHOCYTES
Ellen S. Vitetta;Sonia Baur;Jonathan W. Uhr.
Journal of Experimental Medicine (1971)
Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy.
Francis J. Burrows;Elaine J. Derbyshire;Pier Luigi Tazzari;Peter Amlot.
Clinical Cancer Research (1995)
Phase I immunotoxin trial in patients with B-cell lymphoma.
Ellen S. Vitetta;Marvin Stone;Peter Amlot;Joseph Fay.
Cancer Research (1991)
The University of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center
Baylor College of Medicine
The University of Texas Southwestern Medical Center
University of Pennsylvania
The Ohio State University
German Cancer Research Center
New York State Department of Health
The University of Texas at Austin
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: